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Mechanical phenotyping of primary human
skeletal stem cells in heterogeneous populations
by real-time deformability cytometry†
Miguel Xavier,ab Philipp Rosendahl,c Maik Herbig,c Martin Kra¨ter,d Daniel Spencer,a
Martin Bornha¨user,d Richard O. C. Oreﬀo,b Hywel Morgan,a Jochen Guckc and
Oliver Otto*c
Skeletal stem cells (SSCs) are a sub-population of mesenchymal stromal cells (MSCs) present in bone marrow
with multipotent diﬀerentiation potential. A current unmet challenge hampering their clinical translation
remains the isolation of homogeneous populations of SSCs, in vitro, with consistent regeneration and
diﬀerentiation capacities. Cell stiﬀness has been shown to play an important role in cell separation using
microfluidic techniques such as inertial focusing or deterministic lateral displacement. Here we report that the
mechanical properties of SSCs, and of a surrogate human osteosarcoma cell line (MG-63), diﬀer significantly
from other cell populations found in the bone marrow. Using real-time deformability cytometry, a recently
introduced method for cell mechanical characterization, we demonstrate that both MG-63 and SSCs are
stiﬀer than the three primary leukocyte lineages (lymphocytes, monocytes and granulocytes) and also stiﬀer
than HL-60, a human leukemic progenitor cell line. In addition, we show that SSCs form a mechanically
distinct sub-population of MSCs. These results represent an important step towards finding the bio-physical
fingerprint of human SSCs that will allow their label-free separation from bone marrow with significant
physiological and therapeutic implications.
Insight, innovation, integration
Using real-time deformability cytometry, an innovative microfluidic technique for high-throughput cell mechanical phenotyping, we characterised skeletal
stem cells (SSCs) from human bone marrow within complex samples. SSCs were diﬀerent in both cell size and deformability from granulocytes, monocytes and
lymphocytes, and also from HL-60, a myeloid precursor commonly used as a model system for haematopoietic precursor cells. In addition we show that SSCs
form a mechanically distinct sub-population of mesenchymal stromal cells. A factor still hampering SSC clinical translation is the need to obtain, in vitro, a
large population of cells with homogeneous regeneration and diﬀerentiation capacity. This study should facilitate the development of a deformability-based,
label-free isolation method of SSCs with improved purity and significant physiological and therapeutic implications.
1. Introduction
Advances in medical care have led to a generalised increase in
human life expectancy around the globe.1 However, an aging
population results in an exacerbated burden for healthcare and
increased bone trauma and bone disease are major contributors.
There is thus an unmet need to search for innovative strategies
for bone augmentation allowing bone repair and regeneration.2–4
Skeletal stem cells (SSCs) are a rare multipotent stem cell
population present in the bone marrow stroma. The term skeletal
stem cell is used to refer specifically to the mesenchymal stromal
cell (MSC) sub-population with self-renewing capability, which is
responsible for the regenerative capacity inherent to bone.5–7 SSCs
have osteogenic, chondrogenic and adipogenic potential, which
has long been demonstrated,8,9 and have been extensively studied
for tissue engineering and regenerative and stem cell-based
therapies.5–7,10–12 For example, SSCs have been shown to improve
bone graft integration contributing to the generation of new
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bone in the femoral heads of human patients.2–4 SSCs in
combination with an appropriate scaffold and growth factors
(bone morphogenetic protein – BMP) have also been shown to
contribute to regenerating large calvarial defects in dogs and a
large mandibular defect in a human patient.13 However, one of
the issues restricting their broad clinical application is the need
to isolate homogeneous populations of SSCs in vitro, that display
consistent regeneration and differentiation capacities.14
The enrichment of SSCs from human bone marrow samples
is typically achieved by a density centrifugation to remove most
erythrocytes and granulocytes, followed by immuno-magnetic
separation of bone marrow mononuclear cells (BMMNCs)
labelled with microbeads against a cell surface marker, for
example, the trypsin-resistant cell surface Stro-1 antigen.4,14,15
Stro-1 was first identified by Simmons and Torok-Storb and
binds to approximately 10% of all BMMNCs, from which only
a very small fraction of the Stro-1+ cells (o1%) represent
progenitor cells.16,17 Nevertheless, positive selection of Stro-1+
cells followed by plastic culture adherence has led to marked
enrichment of skeletal progenitor cells with enrichment factors
reaching 950-fold and up to 2000-fold following combinatory
approaches.18,19 However, given the Stro-1 marker is not a
specific marker for the SSC, coupled with the scarcity of SSCs
in bone marrow (estimated ato1 per 10 000 BMMNCs), current
protocols are significantly limited in the purity of SSCs avail-
able following enrichment and selection by plastic culture
adherence.20,21
Consequently, in the absence of a specific SSC antigen,
alternative isolation strategies exploiting distinct phenotypic
features of SSCs oﬀer the potential to improve both yield and
purity. It has long been demonstrated that cell mechanical
properties are intrinsically related to their cytoskeletal structure
which translates directly to diﬀerent cell states, function and
subsequent diﬀerentiation paths.22–27 For example, MSCs stiffen
with both passage number and population doubling; more
deformable cells typically display enhanced differentiation
potential.28 A recent study has also correlated different states
of MSC differentiation potency with elastic modulus.29 However,
there has been no study of the deformability properties of SSCs
in the context of a label-free bio-marker for cell separation.
Microfluidic techniques, operating in laminar flow regime,
are capable of precise and deterministic control over fluid
samples taking advantage of unique physical phenomena
for label-free cell isolation and characterisation.30 Thus, the
application of microfluidic techniques could provide improved
methods for enrichment as part of a suite of label-free
approaches using e.g. inertial microfluidics or deterministic
lateral displacement (DLD).
Both inertial microfluidics and DLD separate cells primarily
based on size, but also in combination with other bio-physical
features such as cell stiﬀness or deformability. Inertial microfluidic
techniques rely on establishing diﬀerent equilibrium positions for
particles flowing within a microfluidic channel. The equilibria are
created by the balance of inertial lift and shear-gradient forces.
DLD uses arrays of row-shifted micropillars to divide a flow stream
into parallel lamellae. Cells of diﬀerent sizes are displaced within
the devices leading to fractionation.30–35 Separation based on
stiffness is based on the fact that two cells of similar size but with
significantly different mechanical properties will have different
effective radii. Accordingly, the more deformable or compliant cell
will be squeezed by high shear forces and therefore appear smaller
than its actual size. Holmes et al.32 have shown that by deforming
cells in a DLD device operated at increasing pressure (flow rates), it
is possible to discriminate between sub-populations of leukocytes
(T-lymphocytes and neutrophils) through a combination of size
and deformation differences.
Real-time deformability cytometry (RT-DC) is a contactless
microfluidic technique for high-throughput screening of cell
mechanical properties (Fig. 1a). Cells, suspended in a viscosity-
adjusted medium, are deformed by shear and normal stresses as
they pass through a narrow constriction (Fig. 1b and c).36,37 The
technique determines the size and shape of each cell, with image
analysis performed in real-time, at rates of 1000 s1. The ability
to study large populations of cells, in a relatively short time
window, is an important advantage over other serial mechanical
characterisation techniques such as atomic force microscopy,28
micropipette aspiration38 or optical stretching.26,28
The current study has used RT-DC to measure the mechanical
properties of a Stro-1+ human osteosarcoma cell line (MG-63)
and enriched populations of primary human SSCs. Data was
compared with other cell populations present in the bone
marrow, including leukocytes from human blood, and a human
myeloid progenitor cell line – HL-60.39 We hypothesise that
deformability would provide a biophysical feature of SSCs that
can be applied in a combinatorial approach, together with
other discriminatory features such as size or surface marker
expression, to improve the yield and specificity of sorted
homogenous SSC populations.
2. Materials and methods
2.1 Real-time deformability cytometry
RT-DCmeasurements were performed as previously described.36,37
Briefly, a microfluidic chip was made out of PDMS using soft-
lithography and sealed with a glass cover-slip after plasma surface
activation. The microfluidic chip consisted of two reservoirs con-
nected by a 300 mm long constriction channel with a 30 mm by
30 mm cross-section. A row of filter posts at the inlet prevents
the channel from clogging by cell clumps and debris.
For measurement, cells were harvested, mixed appropriately,
centrifuged and re-suspended in a 0.5% methylcellulose solution
in PBS at a concentration of 1–2  106 cells per mL. For
measurements of SSCs, cells were first filtered through a 70 mm
cell strainer. The cell suspension was drawn into 1 mL syringes
and connected to the chip by polymer tubing. Cells were pumped
with a syringe pump at a constant flow rate for 2 minutes
before collecting data, to stabilise flow. Data was acquired in
real-time with a high-speed CMOS camera (MC1362; Mikrotron,
Unterschleissheim, Germany), operating at 2000 fps, and illu-
minated by a high-power LED (CBT-120, 462 nm; Luminus
devices, Woburn, MA, USA) through a 40 objective from an
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inverted microscope (Axiovert 200M, Carl Zeiss, Oberkochen,
Germany) at the end of the 300 mm long constriction channel
where the cell shape has reached steady state (Fig. 1a and b). An
image processing algorithm implemented on C/LabVIEW was
used to determine the cell cross-sectional area and circularity,
defined as c ¼ 2 ﬃﬃﬃﬃﬃﬃpAp l, where A is the projected area of the cells
and l its perimeter. Cells deform into a characteristic bullet-like
shape at the end of the constriction (Fig. 1b)36,37 and are
characterised by their deformation (D = 1  c), which defines
the deviation of the cell shape from a perfect circle (c = 1).
Typically, a minimum of 2000 or 5000 (for measurements with
leukocytes) events was acquired at flow rates of 0.16 mL s1
(0.04 mL s1 sample + 0.12 mL s1 sheath) and 0.32 mL s1
(0.08 mL s1 sample + 0.24 mL s1 sheath). Measurements of all
samples were repeated at least three times. As a reference, cell
circularity was obtained in a section of the microfluidic chip with
large cross section where deformation does not occur (ESI†).
Both cell deformation and size are displayed using scatter
plots and an example is shown in Fig. 1d for a flow rate of
0.32 mL s1. Cell deformation is dependent on cell size for
RT-DC measurements, i.e. having two cells that only diﬀer in
size, the larger will deformmore as it is exposed to higher shear
stresses. An analytical model was developed to disentangle both
contributions by calculating the hydrodynamic flow profile
around a moving cell in confinement, and coupling the resulting
surface stress to a linear elastic model.40 The model predicts the
resulting deformation and introduces isoelasticity lines to the
scatter plots (Fig. 1d). These lines divide a typical deformation
scatter plot into areas of identical stiﬀness for multiples of a
given elastic modulus E0 (Fig. 1d).
36,37,40 This enables the cell
deformation to be determined independently of hydrodynamic
stresses, thus permitting comparison between cells with signifi-
cant size diﬀerences.36,40
2.2 Statistical analysis
A two-dimensional mixture model using a normal distribution
for cell size and a lognormal distribution for deformation
was applied using R and rebmix.41–43 These assumptions are
justified since the lower boundary of D = 0 skews the prob-
ability density function towards larger deformation values. The
algorithm allowed the unbiased assignment of measurement
events into clusters that represent different cell populations.
Subsequent 1-dimensional linear mixed model analysis based
on the R-package lme4 (Fig. 2b) enabled a statistical compar-
ison with respect to cell size and cell deformation.44,45
To represent the experimental situation, one fixed and one
random effect were taken into account to model the difference
between sub-populations of cells and to consider the variation
of biological replicates, respectively. The random effect was
allowed to lead to random intercepts and slopes. P-values were
calculated by a likelihood ratio test comparing the full model
with a model lacking the fixed effect term. The results were
obtained from at least 3 independent measurements and all
data analysis was treated equally.
2.3 Cell culture
2.3.1 MG-63. MG-63 human osteosarcoma cells, from pas-
sages 24 to 26, were cultured in DMEM supplemented with 10%
FCS, 100 U mL1 penicillin and 100 mg mL1 streptomycin and
maintained in a humidified chamber at 37 1C and 5% CO2.
Medium was replenished every 2–3 days and the cells were
routinely sub-cultured assuring a maximum confluence of 70%,
being detached using a 0.025% (w/v) Trypsin–EDTA solution
with 0.05% glucose for 5 minutes at 37 1C and re-plated at a cell
seeding density of 2–4  104 cells per cm2. MG-63 were used in
this work as a model for SSCs as a Stro-1+ cell line.
Fig. 1 Real-time deformability cytometry. (a) Schematic of the RT-DC set-up. (b) Shows real images of a single cell deforming into the characteristic
bullet-like shape in a 20 mm  20 mm constriction within the microfluidic chip depicted in (a); scale bar: 50 mm. (c) Shows the shear and normal stresses
acting on a cell flowing in the constriction channel; black arrows indicate stress directions; surface colour indicates magnitude and blue lines show the
flow profile in a co-moving reference frame. (d) Shows deformation vs. projected size (in mm2) of HL-60 cells, measured at 0.32 mL s1, including
isoelasticity lines, which divide a typical deformation scatter plot from a 30 mm  30 mm constriction channel into areas of identical stiﬀness for multiples
of a given elastic modulus (E0). Solid black line highlights 50%-density contour. Adapted from Otto et al., Nat. Method, 2015, 12, 199–202.
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2.3.2 HL-60. HL-60, a human peripheral blood promyelo-
cytic leukemia cell line, from passages 16 to 18, was cultured in
RPMI-1640 medium supplemented with 10% FCS, 100 U mL1
penicillin and 100 mg mL1 streptomycin and maintained in a
humidified chamber at 37 1C and 5% CO2. The cells were split
every two days to a concentration of 2  105 cells per mL.
2.3.3 Isolation and expansion of human mesenchymal
stromal cells. Human mesenchymal stromal cells (MSCs) that
have not been enriched for Stro-1+ expression were isolated
from bone marrow aspirates of healthy volunteers through
density centrifugation followed by plastic culture adherence.
The MSCs were cultured to confluence in monolayer cultures in
a-MEM supplemented with 10% FCS, 100 U mL1 penicillin
and 100 mg mL1 streptomycin and maintained in a humidified
chamber at 37 1C and 5% CO2. This study was conducted under
the ethical approval of the Technische Universita¨t Dresden
(EK263122004).
2.3.4 Isolation and expansion of Stro-1+ immuno-selected
primary human skeletal stem cells. Human bone marrow
samples were obtained from four individuals following routine
total hip replacement surgery at Southampton General Hospital
or the Spire Southampton Hospital. Only tissue that would have
been discarded was used in this study with approval of the
Southampton and South West Hampshire Research Ethics
Committee (Ref No. 194/99/1 & 210/01).
Following extraction of cells from the bonemarrow samples and
extensive washes in plain a-MEM, the cell suspension was filtered
through a 40 mm cell strainer and layered upon Lymphoprept for
removal of erythrocytes and the majority of granulocytes by density
centrifugation. The bone marrow mononuclear cell fraction was
collected from the ‘buﬀy coat’ at the interphase between the
Lymphoprept and the culture medium and incubated with a
mouse hybridoma supernatant monoclonal (IgM) anti-human
Stro-1 antibody produced in loco. The SSC-enriched Stro-1+ cell
population was isolated by magnetic separation of cells labelled
with anti-mouse IgM microbeads, as previously published.15
The enriched SSCs were cultured to confluence in monolayer
cultures in a-MEM supplemented with 10% FCS, 100 U mL1
penicillin and 100 mg mL1 streptomycin and maintained in a
humidified chamber at 37 1C and 5% CO2. For the RT-DC
measurements, cells were harvested using a 0.025% (w/v)
Trypsin–EDTA solution with 0.05% glucose for 5 minutes at
37 1C and pre-treated with collagenase IV (200 mg mL1) when
needed. Cells were not passaged during cell expansion.
Fig. 2 Real-time deformability cytometry of (a) MG-63 mixed 1 : 1 with HL-60; (b) shows deformation vs. projected size (in mm2) of MG-63 and HL-60
combining events from 3 measurements unbiasedly allocated using mixture models, with respective histograms demonstrating the cells size and
deformation distributions. The p-values were calculated using linear mixed models. (c) Stro-1+-enriched skeletal stem cells; (d) human bone marrow
mesenchymal stromal cells and (e) Stro-1+-enriched skeletal stem cells mixed 1 : 1 with HL-60; All scatter plots show deformation vs. cell size (cross-
sectional area) and experiments were carried out at 0.32 mL s1 through the 30 mm  30 mm cross-sectional channel; colour indicates density scale and
each dot is representative of a single event from a total of 2000 events. Images (f)–(h) show representative captures of the cells from (a, c and e) with the
red line representing the contour determined by image analysis in real-time.
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2.3.5 Human blood sample collection and preparation.
Ethical approval was given by the Isle of Wight, Portsmouth
and South East Hampshire Local Research Ethics Committee
and written consent was obtained from all participants. Blood
samples were collected from healthy volunteers through a
finger prick punctured using a safety lancet into blood collec-
tion tubes coated with sodium citrate to block the coagulation
cascade. The tubes were kept on a roller at room temperature
and subsequent experimental work was carried out within 2 to
3 hours after collection. Erythrocyte lysis was performed by
addition of a lysis solution (0.12% formic acid, 0.05% saponin
in distilled water) to the whole blood in a 12 : 1 ratio. The
reaction occurred under constant mixing for 6 seconds and was
halted by immediate addition of 5.3 mL of an isosmotic
quencher (0.6% w/v sodium carbonate, 3% sodium chloride
solution in distilled water) per microliter of whole blood at the
start of the procedure.46
2.4 Materials
BioWhittakers Dulbecco’s modified Eagle medium with glucose
and L-glutamine (DMEM), Alpha minimum essential medium
with deoxyribonucleotides, ribonucleotides and ultra-glutamine
(a-MEM), Dulbecco’s phosphate buﬀered saline (DPBS), foetal calf
serum (FCS) and trypsin/EDTA were obtained from Lonza (Basel,
Switzerland). RPMI-1640 culture medium was obtained from Life
Technologies (Carlsbad, CA, USA). Penicillin-streptomycin 100,
AB human serum, Bovine serum albumin, collagenase IV, ethylene-
diamine tetra-acetic acid (EDTA) and methylcellulose were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Lymphoprept
was bought from Stem Cell Technologies (Vancouver, Canada).
Anti-mouse IgM microbeads, LS MACSt columns and the
QuadroMACSt separator were purchased from Miltenyi Biotec
(Bergisch Gladbach, Germany). S-Monovettes 9NC tri-sodium
citrate tubes were obtained from Sarstedt (Nu¨mbrecht, Germany)
and Sylgard 184 polydimethylsiloxane (PDMS) was purchased
from VWR (Darmstadt, Germany). All reagents were used as
received and according to the manufacturer’s recommendations.
3. Results and discussion
3.1 HL-60, MG-63, MSCs and skeletal stem cells
MG-63, MSCs and SSCs are large cells with considerable
heterogeneity.47 The channel in the RT-DC device needed to
be wide enough to allow the larger cells to flow through, but
also not so large that smaller cells would not deform.36 HL-60
are generally measured using 20 mm  20 mm cross-section
channels, but for this work 30 mm  30 mm channels were used
to accommodate the larger MG-63 and SSCs. Consequently, the
first experiments were to verify that the deformation of HL-60
cells (a model for human haematopoietic progenitor cells)
could be measured in these larger channels at diﬀerent flow
rates (Fig. 1d and ESI,† Fig. S1).
To compare the deformability of HL-60 and MG-63, both cells
were mixed in approximately equal numbers and measured
simultaneously. The deformation scatter plot for the two cell
populations demonstrated a clear discrimination in size and
deformation (Fig. 2a and ESI,† Fig. S2). Using a two-dimensional
mixture model and linear mixed models, as described in the
Materials and methods section of this manuscript, MG-63
cells were observed to be larger (p o 0.0001) and deform less
( p o 0.01) than HL-60 cells (Fig. 2b). Analysis of captured cell
images (Fig. 2f and g) confirmed that the HL-60 cells were
smaller and observed to be more elongated (more deformed)
than the larger MG-63. As previously described, larger cells are
subject to higher shear gradient stresses as the cells flow closer
to the channel walls. The fact that MG-63 are both larger and less
deformed than HL-60 cells indicates that MG-63 have a higher
Young’s modulus.
SSC size and deformation were subsequently measured in
isolation (Fig. 2c and ESI,† Fig. S3). The population of very
small particles was debris from the high ECM production of
confluent cells. SSCs displayed a much broader distribution
reflecting the population heterogeneity. This was expected given
these are primary cells from human samples enriched via Stro-1
antibody selection, but still represent a heterogeneous popula-
tion. Despite the greater spread, the SSC population almost
matches the MG-63 osteoblast-like cells in terms of size and
deformation. This can also be seen for the representative images
in Fig. 2g and h. Although it is hard to find agreement in the
published values of the Young’s modulus of MSCs, probably
owing to their ambiguity and diﬀerent tissue sources,48 studies
report that MSCs are typically stiﬀer than their diﬀerentiation
progenies or similar to osteoblasts.24,38,49,50
In fact, measurement of MSCs in isolation (Fig. 2d and ESI,†
Fig. S4) shows a population that is heterogeneous in size and
encompasses the SSC population shown in Fig. 2c. This sup-
ports the fact that SSCs are a sub-population found within the
group of progenitors that represent the MSCs. Interestingly,
Stro-1-enriched SSCs diﬀer significantly in deformation from
MSCs ( p o 0.05), highlighting the potential of our method for
label-free identification and sorting of skeletal stem cells.
Measurement of a mixture of SSCs and HL-60 cells together
(Fig. 2d and ESI,† Fig. S5), displayed distinct populations
though with a degree of overlap. SSCs were observed to be
larger ( p o 0.001), however, their deformation was generally
lower than that of HL-60 ( po 0.01), indicating higher stiﬀness.
In a previous study it was shown that HSCs derived from
human bone marrow are softer than HL-60.36 As a consequence
the current studies imply that SSCs are stiﬀer than human bone
marrow-derived HSCs.
3.2 Mixed leukocyte and skeletal stem cell populations
For label-free isolation of SSCs from human bone marrow to
reach successful clinical application, SSCs should be signifi-
cantly diﬀerent from leukocytes. Leukocytes arise from HSCs,
which share a similar stem cell niche as SSCs in the bone
marrow, and can be divided into three main populations:
lymphocytes, monocytes and granulocytes, with neutrophils
representing the vast majority of the latter.51–53 Leukocytes
were isolated from human blood samples by selective lysis
and measured by RT-DC. As shown in Fig. 3a (ESI,† Fig. S6),
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it was possible to discriminate between lymphocytes (Fig. 3b)
and granulocytes/monocytes (Fig. 3c), with lymphocytes seen to
be the smallest cells and deforming less than granulocytes and
monocytes ( p o 0.001).53
It is broadly accepted that white blood cells are highly
deformable. Indeed, leukocytes’ inherent ability to deform is
important in their immune function and methods for deter-
mining impaired leukocyte deformability have been previously
proposed for the diagnostics of certain conditions such as
trauma or sepsis.25,54,55
The scatter plots in Fig. 3d (ESI,† Fig. S7) and Fig. 3e (ESI,†
Fig. S8), show RT-DC measurements for human leukocytes mixed
withMG-63 or SSCs, respectively. The data has been analysed using
a two-dimensional mixturemodel and linear mixedmodels (Fig. 3f)
and it reveals that all cell types can be discriminated based on size
and deformation with statistical significance. Although the MG-63
and SSCs are the largest cells measured, they deform less ( po 0.01
for MG-63; not significant for SSCs) than granulocytes and mono-
cytes. The two leukocyte sub-populations are diﬃcult to resolve in
Fig. 3d and e due to scaling, but comparison of these figures with
Fig. 3a show that the two leukocyte sub-populations are located
within isoelasticity lines (Fig. 1c) of lower Young’s modulus indicat-
ing that both, MG-63 and SSCs, have a Young’s modulus larger
than any sub-population of leukocytes.
This provides a possibility for exploiting novel mechanical-
based sorting strategies for SSCs. The fact that SSCs form a
mechanically diﬀerent sub-population within MSCs of higher
deformability clearly points in this direction and is in agreement
with current literature indicating that cells of higher potency tend
to deform more.28 Taking advantage of the high-throughput of
RT-DC, SSCs could be detected and sorted in real-time using an
integrated cell sorting mechanism. Alternatively, passive label-free
sorting techniques such as DLD or inertial microfluidics could be
used as these have been shown to be sensitive to diﬀerences in
both cell size and deformation.32–35 One successful example of
label-free sorting of rare cells was the use of DLD to isolate
circulating tumour cells from cancer patients to aid in diagnosis
and guided therapies.56 The system completely depletes whole
blood of red blood cells and platelets followed by negative selec-
tion of CD45+ and CD66b+ cells by magnetophoresis. It may be
possible to use a similar approach to isolate SSCs out of hetero-
geneous samples such as the bone marrow.
4. Conclusions
The current study has demonstrated significant diﬀerences in
size and deformability between skeletal stem cells, mesenchymal
Fig. 3 Real-time deformability cytometry of (a) leukocytes obtained from erythrocyte-lysed human whole blood; images (b) and (c) show representative
captures of leukocytes when flowing at 0.32 mL s1 through the 30 mm  30 mm cross-sectional channel with the red line representing the contour
determined by image analysis in real-time; (d) MG-63 mixed 1 : 2 with human leukocytes; and (e) Stro-1+-enriched skeletal stem cells mixed 1 : 2 with
human leukocytes; showing scatter plots of deformation vs. cell size (cross-sectional area); colour indicates density scale and each dot is representative
of a single event from a total of 5000 events. (f) Bar chart summarising size and deformation of leukocytes, HL-60, MG-63, Stro-1+-enriched skeletal
stem cells and MSCs measured by real-time deformability cytometry. Values represent mean  SD (N Z 3; *p o 0.05, **p o 0.01, ***p o 0.001).
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stromal cells and leukocytes. Critically, primary human SSCs
are stiﬀer when compared to HL-60, a myeloid progenitor cell
line, and to all main leukocyte populations (lymphocytes,
monocytes and granulocytes) after RBC-lysis. SSCs were mea-
sured after expansion, following adherence on tissue culture
plastic and thus it will be interesting to determine whether
such large diﬀerence is also observed for freshly harvested cells.
Since the bone marrow is a highly complex tissue with multiple
cell types displaying overlapping features, SSC isolation will not
depend solely on their separation from cells of the haemato-
poietic lineage but also from other adherent cell populations
such as fibroblasts or endothelial cells.18,19,57 These cells may
be similar in size and/or deformability.
The findings reported in this paper demonstrate the potential for
exploiting diﬀerences in cell stiﬀness within a new deformability-
based strategy to improve SSC isolation with significant physio-
logical and therapeutic implications and the potential for their
clinical translation.
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